PRPH logo

ProPhase Labs (PRPH)

Profile

Full Name

ProPhase Labs, Inc.

Ticker Symbol

PRPH

Exchange

NASDAQ

Sector

Healthcare

Industry

Diagnostics & Research

Country

United States

IPO

April 4, 1994

Indexes

Not included

Website

http://www.prophaselabs.com

Employees

96

Key Details

Price

$0.27(-4.39%)

Market cap

Last Dividend

$0.30

TTM Dividend yield

-

Annual revenue

$6.77M(-80.65% YoY)

Annual EPS

-$2.61(-166.33% YoY)

PE ratio

-

Next earnings date

May 9, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$0.27
PRPH price is $0.27

30-Day Relative Volume

1.12
PRPH 30-day relative volume is 1.12

Price Performance

Price Today change

-4.39%
PRPH price is down -4.39% today

Price YTD change

-64.78%
PRPH price is down -64.78% since January 1st

Price 1-year change

-95.73%
PRPH price is down -95.73% year-on-year

Price 3-year change

-96.78%
PRPH price is down -96.78% over the past 3 years

Price Range

Price All-time high

$23.00
PRPH price is currently -98.84% below its historical high of $23.00

Price 3-year low

$0.22
PRPH price is currently +21.68% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$11.21M
PRPH market capitalization is $11.21 million

Market cap 3-year change

-91.29%
PRPH market capitalization is down -91.29% over the past 3 years

Market cap All-time high

$269.49M
PRPH market capitalization is currently -95.84% below its historical high of $269.49 million

Market cap sector rank

21.3%
PRPH market capitalization is higher than 21.3% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+132.08%
PRPH shares outstanding is up +132.08% year-on-year

Shares Outstanding 3-Year Change

+170.43%
PRPH shares outstanding is up +170.43% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

1.63
PRPH beta is 1.63

200-day SMA

$1.51
PRPH price is currently -82.22% below its 200-day simple moving average

50-day SMA

$0.38
PRPH price is currently -29.70% below its 50-day simple moving average

RSI

40.96
PRPH 14-day relative strength index is 40.96

Volume

1.12
PRPH 30-day relative volume is 1.12

ATR

$0.07
PRPH average true range is $0.07

10-day Historical Volatility

225.07%
PRPH 10-day historical volatility is 225.07%

Dividend

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Events

Last Paid Dividend

$0.30
PRPH last dividend was $0.30 per share, with an ex-dividend date of May 24, 2022

Next Dividend

-
PRPH next dividend has not yet been announced

Dividend per share

Dividend per share

-
PRPH annual dividend per share value is unknown

Dividend per share Sector Rank

-
PRPH annual dividend per share is unknown

Dividend per share 1-Year Change

-
PRPH annual dividend per share 1-year change is unknown

Dividend per share 3-Year Change

-
PRPH annual dividend per share 3-year change is unknown

Dividend yield

Dividend yield

-
PRPH annual dividend yield value is unknown

Dividend yield Sector Rank

-
PRPH annual dividend yield is unknown

Other

Payout ratio

-
PRPH annual payout ratio value is unknown

Dividends paid

-
PRPH annual dividends paid value is unknown

Free cash flow

-$18.44M
PRPH annual free cash flow is -$18.44 million

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$6.77M
PRPH annual revenue is $6.77 million

Revenue Analysts estimate

$21.36M
PRPH annual revenue is currently -68.30% lower than the consensus analysts' forecast

Revenue 1-year change

-80.65%
PRPH annual revenue is down -80.65% year-on-year

Revenue Sector rank

23.4%
PRPH annual revenue is higher than 23.4% of companies in Healthcare sector

EPS

EPS

-$2.61
PRPH annual earnings per share is -$2.61

EPS Analysts estimate

-$0.56
PRPH annual earnings per share is currently +366.07% higher than the consensus analysts' forecast

EPS 1-year change

-166.33%
PRPH annual earnings per share is down -166.33% year-on-year

EPS Sector rank

33.14%
PRPH annual earnings per share is higher than 33.14% of companies in Healthcare sector

Profit

Gross profit

-$150.00K
PRPH annual gross profit is -$150.00 thousand

Gross margin

-2.22%
PRPH annual gross profit margin is -2.22%

Operating profit

-$38.63M
PRPH annual operating income is -$38.63 million

Operating margin

-570.59%
PRPH annual operating profit margin is -570.59%

Net income

-$53.36M
PRPH annual net profit is -$53.36 million

Net margin

-788.24%
PRPH annual net profit margin is -788.24%

Expenses

Total expenses

$45.40M
PRPH annual total expenses is $45.40 million

Operating expenses

$38.48M
PRPH annual total operating expenses is $38.48 million

Cost of goods sold

$6.92M
PRPH annual cost of goods sold is $6.92 million

Selling, general & administrative expenses

$37.88M
PRPH annual SGA is $37.88 million

Depreciation and amortization

$6.64M
PRPH annual depreciation & amortization is $6.64 million

Interest expense

$3.35M
PRPH annual interest expense is $3.35 million

Income tax

$7.20M
PRPH annual income tax is $7.20 million

EBIT & EBITDA

EBIT

-$38.98M
PRPH annual earnings before interest & taxes is -$38.98 million

EBITDA

-$32.34M
PRPH annual EBITDA is -$32.34 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$63.20M
PRPH annual total assets is $63.20 million

Non current assets

$32.56M
PRPH annual long term assets is $32.56 million

Current assets

$30.64M
PRPH annual total current assets is $30.64 million

Cash and cash equivalents

$678.00K
PRPH annual cash & cash equivalents is $678.00 thousand

Accounts receivable

$34.90M
PRPH annual accounts receivable is $34.90 million

Inventory

$1.14M
PRPH annual inventory is $1.14 million

Liabilities

Total liabilities

$55.85M
PRPH annual total liabilities is $55.85 million

Long term liabilities

$23.71M
PRPH annual total long term liabilities is $23.71 million

Current liabilities

$32.13M
PRPH annual total current liabilities is $32.13 million

Accounts payable

$13.72M
PRPH annual accounts payable is $13.72 million

Debt

Total debt

$24.57M
PRPH annual total debt is $24.57 million

Total debt 1-year change

+33.14%
PRPH annual total debt is up +33.14% year-on-year

Long term debt

$18.00M
PRPH annual long term debt is $18.00 million

Short term debt

$6.57M
PRPH annual short term debt is $6.57 million

Equity & Capital

Shareholders equity

$7.35M
PRPH annual stockholders equity is $7.35 million

Book value

$7.35M
PRPH annual book value is $7.35 million

Retained earnings

-$58.39M
PRPH annual retained earnings is -$58.39 million

Working capital

-$1.50M
PRPH annual working capital is -$1.50 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$17.54M
PRPH annual cash flow from operations is -$17.54 million

Cash from operations 1-year change

-47.53%
PRPH annual cash flow from operations is down -47.53% year-on-year

Cash from investing

$2.42M
PRPH annual cash flow from investing activities is $2.42 million

Cash from investing 1-year change

+276.92%
PRPH annual cash flow from investing activities is up +276.92% year-on-year

Cash from financing

$14.19M
PRPH annual cash flow from financing activities is $14.19 million

Cash from financing 1-year change

+146.4%
PRPH annual cash flow from financing activities is up +146.4% year-on-year

CAPEX

CAPEX

$906.00K
PRPH annual capital expenditures is $906.00 thousand

CAPEX 1-year change

-56.53%
PRPH annual capital expenditures is down -56.53% year-on-year

Free Cash Flow

Free cash flow

-$18.44M
PRPH annual free cash flow is -$18.44 million

Free cash flow 1-year change

-32.01%
PRPH annual free cash flow is down -32.01% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-2.22%
PRPH annual gross profit margin is -2.22%

Operating margin

-570.59%
PRPH annual operating profit margin is -570.59%

Net margin

-788.24%
PRPH annual net profit margin is -788.24%

ROA & ROE

ROA

-68.80%
PRPH annual return on assets is -68.80%

ROE

-188.11%
PRPH annual return on equity is -188.11%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
PRPH price to earnings ratio value is unknown

PE ratio Sector rank

-
PRPH price to earnings ratio is unknown

PB Ratio

PB ratio

1.52
PRPH price to book ratio is 1.52

PB ratio Sector rank

56.51%
PRPH price to book ratio is higher than 56.51% of companies in Healthcare sector

PS Ratio

PS ratio

1.66
PRPH price to sales ratio is 1.66

PS ratio Sector rank

39.49%
PRPH price to sales ratio is higher than 39.49% of companies in Healthcare sector

Enterprise value

Enterprise value

$35.11M
PRPH enterprise value is $35.11 million

Enterprise value Sector rank

37.16%
PRPH enterprise value is higher than 37.16% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-1.09
PRPH EV/EBITDA is -1.09

EV/EBITDA Sector rank

41.22%
PRPH EV/EBITDA is higher than 41.22% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

0.95
PRPH annual current ratio is 0.95

Quick ratio

0.92
PRPH annual quick ratio is 0.92

Leverage

Debt to equity

2.02
PRPH annual debt to equity ratio is 2.02

Interest coverage ratio

-11.64
PRPH annual interest coverage ratio is -11.64

Risk & Stability

Piotroski F-Score

1
PRPH piotroski f-score is 1

Altman Z-Score

-3.13
PRPH altman z-score is -3.13

Analyst ratings

Recent major analysts updates

Feb 21, 24 HC Wainwright & Co.
Buy
Nov 10, 23 HC Wainwright & Co.
Buy
Aug 14, 23 HC Wainwright & Co.
Buy
Jun 2, 23 HC Wainwright & Co.
Buy
May 12, 23 HC Wainwright & Co.
Buy
Mar 8, 23 HC Wainwright & Co.
Buy
Feb 23, 23 HC Wainwright & Co.
Buy
Feb 16, 23 HC Wainwright & Co.
Buy
Feb 7, 23 HC Wainwright & Co.
Buy
Nov 11, 22 HC Wainwright & Co.
Buy

Institutional Ownership

Similar stocks

Kairos Pharma (KAPA)
SYBX logo
Synlogic (SYBX)
ABVC logo
ABVC BioPharma (ABVC)
MRKR logo
Marker Therapeutics (MRKR)
AFMD logo
Affimed NV (AFMD)
BRTX logo
BioRestorative Therapies (BRTX)
TXMD logo
TherapeuticsMD (TXMD)
PSTV logo
Plus Therapeutics (PSTV)
Hong Kong Pharma Digital Technology Holdings Limited (HKPD)
  • What is the ticker symbol for ProPhase Labs?
  • Does ProPhase Labs pay dividends?
  • What sector is ProPhase Labs in?
  • What industry is ProPhase Labs in?
  • What country is ProPhase Labs based in?
  • When did ProPhase Labs go public?
  • Is ProPhase Labs in the S&P 500?
  • Is ProPhase Labs in the NASDAQ 100?
  • Is ProPhase Labs in the Dow Jones?
  • When was ProPhase Labs's last earnings report?
  • When does ProPhase Labs report earnings?
  • Should I buy ProPhase Labs stock now?

What is the ticker symbol for ProPhase Labs?

The ticker symbol for ProPhase Labs is NASDAQ:PRPH

Does ProPhase Labs pay dividends?

No, ProPhase Labs does not pay dividends

What sector is ProPhase Labs in?

ProPhase Labs is in the Healthcare sector

What industry is ProPhase Labs in?

ProPhase Labs is in the Diagnostics & Research industry

What country is ProPhase Labs based in?

ProPhase Labs is headquartered in United States

When did ProPhase Labs go public?

ProPhase Labs's initial public offering (IPO) was on April 4, 1994

Is ProPhase Labs in the S&P 500?

No, ProPhase Labs is not included in the S&P 500 index

Is ProPhase Labs in the NASDAQ 100?

No, ProPhase Labs is not included in the NASDAQ 100 index

Is ProPhase Labs in the Dow Jones?

No, ProPhase Labs is not included in the Dow Jones index

When was ProPhase Labs's last earnings report?

ProPhase Labs's most recent earnings report was on Mar 31, 2025

When does ProPhase Labs report earnings?

The next expected earnings date for ProPhase Labs is May 9, 2025

Should I buy ProPhase Labs stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page